Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries : the Nobori 1 trial
Identifieur interne : 009386 ( Main/Exploration ); précédent : 009385; suivant : 009387
Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries : the Nobori 1 trial
Auteurs : Bernard Chevalier [France] ; Patrick W. Serruys [Pays-Bas] ; Sigmund Silber [Allemagne] ; Eulogio Garcia [Espagne] ; Harry Suryapranata [Pays-Bas] ; Karl Hauptmann [Allemagne] ; William Wijns [Belgique] ; Gerhard Schuler [Allemagne] ; Farzin Fath-Ordoubadi [Royaume-Uni] ; Stephen Worthley [Australie] ; Leif Thuesen [Danemark] ; Ian Meredith [Australie] ; Marco Bressers [Pays-Bas] ; Hirofumi Nagai [Japon] ; Dragica Paunovic [Belgique]Source :
- EuroIntervention [ 1774-024X ] ; 2007.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
Background: We studied the Nobori<TM> coronary stent coated with a bioabsorbable polymer and the antiproliferative agent Biolimus A9 which may reduce neointimal formation. Methods and results: Patients undergoing percutaneous coronary intervention for de novo lesions in up to two native coronary arteries, in 29 centres across Europe, Asia and Australia were randomly (2:1) assigned to receive the Biolimus A9 eluting stent Nobori<TM> (85 patients) or paclitaxel eluting stent Taxus® (35 patients). The two groups were well matched in baseline characteristics. The primary end point of non-inferiority for in-stent late loss of Nobori<TM> stent versus Taxus® stent, at 9 months, was reached with the values of 0.15±0.27 mm with Nobori<TM> stent and 0.32±0.33 mm with Taxus® stent (p=0.006). Neointimal volume obstruction was 2.2±6.0% and 8.9±9.2% for Nobori<TM> and Taxus® stent respectively (p=0.017). The rates of death, myocardial infarction and any target vessel revascularisation at 9 months were 0%, 4.7%, and 7.1% respectively for Nobori<TM> stent, and 0%, 8.6% and 14.3% respectively for Taxus® stent. Clinically-driven target lesion revascularisation rate was 0% for Nobori<TM> stent and 2.9% for Taxus® stent. Stent thrombosis rates at 9 months were 0% in both groups. Conclusions: In this trial the Nobori<TM> Biolimus A9 eluting stent proved to be safe and effective in reducing neointimal proliferation. The long term safety remains to be confirmed during the extended follow-up period of 5 years.
Affiliations:
- Allemagne, Australie, Belgique, Danemark, Espagne, France, Japon, Pays-Bas, Royaume-Uni
- Angleterre, Bavière, Communauté de Madrid, District de Haute-Bavière, District de Leipzig, Grand Manchester, Hollande-Méridionale, Région de Kantō, Saxe (Land), Île-de-France
- Leipzig, Madrid, Manchester, Munich, Rotterdam, Saint-Denis (Seine-Saint-Denis), Tokyo
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 003E14
- to stream PascalFrancis, to step Curation: 002274
- to stream PascalFrancis, to step Checkpoint: 003671
- to stream Main, to step Merge: 009D83
- to stream Main, to step Curation: 009386
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Randomised comparison of Nobori<<sup>TM</sup>>, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries : the Nobori 1 trial</title><author><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Centre Cardiologique du Nord</s1><s2>Saint-Denis</s2><s3>FRA</s3><sZ>1 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement></placeName></affiliation></author><author><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W." last="Serruys">Patrick W. Serruys</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Erasmus MC</s1><s2>Rotterdam</s2><s3>NLD</s3><sZ>2 aut.</sZ></inist:fA14><country>Pays-Bas</country><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Silber, Sigmund" sort="Silber, Sigmund" uniqKey="Silber S" first="Sigmund" last="Silber">Sigmund Silber</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Kardiologische Gemeinschaftspraxis und HKL</s1><s2>Munich</s2><s3>DEU</s3><sZ>3 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author><author><name sortKey="Garcia, Eulogio" sort="Garcia, Eulogio" uniqKey="Garcia E" first="Eulogio" last="Garcia">Eulogio Garcia</name><affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Gregorio Marañón</s1><s2>Madrid</s2><s3>ESP</s3><sZ>4 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Suryapranata, Harry" sort="Suryapranata, Harry" uniqKey="Suryapranata H" first="Harry" last="Suryapranata">Harry Suryapranata</name><affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Isala Clinic</s1><s2>Zwolle</s2><s3>NLD</s3><sZ>5 aut.</sZ></inist:fA14><country>Pays-Bas</country><wicri:noRegion>Isala Clinic</wicri:noRegion></affiliation></author><author><name sortKey="Hauptmann, Karl" sort="Hauptmann, Karl" uniqKey="Hauptmann K" first="Karl" last="Hauptmann">Karl Hauptmann</name><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Krankenhaus der Barmherzigen Brüder</s1><s2>Trier</s2><s3>DEU</s3><sZ>6 aut.</sZ></inist:fA14><country>Allemagne</country><wicri:noRegion>Trier</wicri:noRegion><wicri:noRegion>Krankenhaus der Barmherzigen Brüder</wicri:noRegion><wicri:noRegion>Krankenhaus der Barmherzigen Brüder</wicri:noRegion></affiliation></author><author><name sortKey="Wijns, William" sort="Wijns, William" uniqKey="Wijns W" first="William" last="Wijns">William Wijns</name><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Onze-Lieve-Vrouw Hospital</s1><s2>Aalst</s2><s3>BEL</s3><sZ>7 aut.</sZ></inist:fA14><country>Belgique</country><wicri:noRegion>Onze-Lieve-Vrouw Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Schuler, Gerhard" sort="Schuler, Gerhard" uniqKey="Schuler G" first="Gerhard" last="Schuler">Gerhard Schuler</name><affiliation wicri:level="3"><inist:fA14 i1="08"><s1>Universitätsklinikum</s1><s2>Leipzig</s2><s3>DEU</s3><sZ>8 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Saxe (Land)</region><region type="district" nuts="2">District de Leipzig</region><settlement type="city">Leipzig</settlement></placeName></affiliation></author><author><name sortKey="Fath Ordoubadi, Farzin" sort="Fath Ordoubadi, Farzin" uniqKey="Fath Ordoubadi F" first="Farzin" last="Fath-Ordoubadi">Farzin Fath-Ordoubadi</name><affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Royal Infirmary</s1><s2>Manchester</s2><s3>GBR</s3><sZ>9 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region></placeName></affiliation></author><author><name sortKey="Worthley, Stephen" sort="Worthley, Stephen" uniqKey="Worthley S" first="Stephen" last="Worthley">Stephen Worthley</name><affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Royal Adelaide Hospital</s1><s2>Adelaide</s2><s3>AUS</s3><sZ>10 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Royal Adelaide Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Thuesen, Leif" sort="Thuesen, Leif" uniqKey="Thuesen L" first="Leif" last="Thuesen">Leif Thuesen</name><affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Skejby Sygehus, Aarhus University Hospital</s1><s2>Aarhus</s2><s3>DNK</s3><sZ>11 aut.</sZ></inist:fA14><country>Danemark</country><wicri:noRegion>Aarhus</wicri:noRegion></affiliation></author><author><name sortKey="Meredith, Ian" sort="Meredith, Ian" uniqKey="Meredith I" first="Ian" last="Meredith">Ian Meredith</name><affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Monash Medical Centre</s1><s2>Clayton, Victoria</s2><s3>AUS</s3><sZ>12 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Monash Medical Centre</wicri:noRegion></affiliation></author><author><name sortKey="Bressers, Marco" sort="Bressers, Marco" uniqKey="Bressers M" first="Marco" last="Bressers">Marco Bressers</name><affiliation wicri:level="3"><inist:fA14 i1="13"><s1>Cardialysis BV</s1><s2>Rotterdam</s2><s3>NLD</s3><sZ>13 aut.</sZ></inist:fA14><country>Pays-Bas</country><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Nagai, Hirofumi" sort="Nagai, Hirofumi" uniqKey="Nagai H" first="Hirofumi" last="Nagai">Hirofumi Nagai</name><affiliation wicri:level="3"><inist:fA14 i1="14"><s1>Terumo Corporation</s1><s2>Tokyo</s2><s3>JPN</s3><sZ>14 aut.</sZ></inist:fA14><country>Japon</country><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Paunovic, Dragica" sort="Paunovic, Dragica" uniqKey="Paunovic D" first="Dragica" last="Paunovic">Dragica Paunovic</name><affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Terumo Europe</s1><s2>Leuven</s2><s3>BEL</s3><sZ>15 aut.</sZ></inist:fA14><country>Belgique</country><wicri:noRegion>Terumo Europe</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">07-0102184</idno><date when="2007">2007</date><idno type="stanalyst">PASCAL 07-0102184 INIST</idno><idno type="RBID">Pascal:07-0102184</idno><idno type="wicri:Area/PascalFrancis/Corpus">003E14</idno><idno type="wicri:Area/PascalFrancis/Curation">002274</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">003671</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">003671</idno><idno type="wicri:doubleKey">1774-024X:2007:Chevalier B:randomised:comparison:of</idno><idno type="wicri:Area/Main/Merge">009D83</idno><idno type="wicri:Area/Main/Curation">009386</idno><idno type="wicri:Area/Main/Exploration">009386</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Randomised comparison of Nobori<<sup>TM</sup>>, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries : the Nobori 1 trial</title><author><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Centre Cardiologique du Nord</s1><s2>Saint-Denis</s2><s3>FRA</s3><sZ>1 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement></placeName></affiliation></author><author><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W." last="Serruys">Patrick W. Serruys</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Erasmus MC</s1><s2>Rotterdam</s2><s3>NLD</s3><sZ>2 aut.</sZ></inist:fA14><country>Pays-Bas</country><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Silber, Sigmund" sort="Silber, Sigmund" uniqKey="Silber S" first="Sigmund" last="Silber">Sigmund Silber</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Kardiologische Gemeinschaftspraxis und HKL</s1><s2>Munich</s2><s3>DEU</s3><sZ>3 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author><author><name sortKey="Garcia, Eulogio" sort="Garcia, Eulogio" uniqKey="Garcia E" first="Eulogio" last="Garcia">Eulogio Garcia</name><affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Gregorio Marañón</s1><s2>Madrid</s2><s3>ESP</s3><sZ>4 aut.</sZ></inist:fA14><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Suryapranata, Harry" sort="Suryapranata, Harry" uniqKey="Suryapranata H" first="Harry" last="Suryapranata">Harry Suryapranata</name><affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Isala Clinic</s1><s2>Zwolle</s2><s3>NLD</s3><sZ>5 aut.</sZ></inist:fA14><country>Pays-Bas</country><wicri:noRegion>Isala Clinic</wicri:noRegion></affiliation></author><author><name sortKey="Hauptmann, Karl" sort="Hauptmann, Karl" uniqKey="Hauptmann K" first="Karl" last="Hauptmann">Karl Hauptmann</name><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Krankenhaus der Barmherzigen Brüder</s1><s2>Trier</s2><s3>DEU</s3><sZ>6 aut.</sZ></inist:fA14><country>Allemagne</country><wicri:noRegion>Trier</wicri:noRegion><wicri:noRegion>Krankenhaus der Barmherzigen Brüder</wicri:noRegion><wicri:noRegion>Krankenhaus der Barmherzigen Brüder</wicri:noRegion></affiliation></author><author><name sortKey="Wijns, William" sort="Wijns, William" uniqKey="Wijns W" first="William" last="Wijns">William Wijns</name><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Onze-Lieve-Vrouw Hospital</s1><s2>Aalst</s2><s3>BEL</s3><sZ>7 aut.</sZ></inist:fA14><country>Belgique</country><wicri:noRegion>Onze-Lieve-Vrouw Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Schuler, Gerhard" sort="Schuler, Gerhard" uniqKey="Schuler G" first="Gerhard" last="Schuler">Gerhard Schuler</name><affiliation wicri:level="3"><inist:fA14 i1="08"><s1>Universitätsklinikum</s1><s2>Leipzig</s2><s3>DEU</s3><sZ>8 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="1">Saxe (Land)</region><region type="district" nuts="2">District de Leipzig</region><settlement type="city">Leipzig</settlement></placeName></affiliation></author><author><name sortKey="Fath Ordoubadi, Farzin" sort="Fath Ordoubadi, Farzin" uniqKey="Fath Ordoubadi F" first="Farzin" last="Fath-Ordoubadi">Farzin Fath-Ordoubadi</name><affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Royal Infirmary</s1><s2>Manchester</s2><s3>GBR</s3><sZ>9 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region></placeName></affiliation></author><author><name sortKey="Worthley, Stephen" sort="Worthley, Stephen" uniqKey="Worthley S" first="Stephen" last="Worthley">Stephen Worthley</name><affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Royal Adelaide Hospital</s1><s2>Adelaide</s2><s3>AUS</s3><sZ>10 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Royal Adelaide Hospital</wicri:noRegion></affiliation></author><author><name sortKey="Thuesen, Leif" sort="Thuesen, Leif" uniqKey="Thuesen L" first="Leif" last="Thuesen">Leif Thuesen</name><affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Skejby Sygehus, Aarhus University Hospital</s1><s2>Aarhus</s2><s3>DNK</s3><sZ>11 aut.</sZ></inist:fA14><country>Danemark</country><wicri:noRegion>Aarhus</wicri:noRegion></affiliation></author><author><name sortKey="Meredith, Ian" sort="Meredith, Ian" uniqKey="Meredith I" first="Ian" last="Meredith">Ian Meredith</name><affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Monash Medical Centre</s1><s2>Clayton, Victoria</s2><s3>AUS</s3><sZ>12 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Monash Medical Centre</wicri:noRegion></affiliation></author><author><name sortKey="Bressers, Marco" sort="Bressers, Marco" uniqKey="Bressers M" first="Marco" last="Bressers">Marco Bressers</name><affiliation wicri:level="3"><inist:fA14 i1="13"><s1>Cardialysis BV</s1><s2>Rotterdam</s2><s3>NLD</s3><sZ>13 aut.</sZ></inist:fA14><country>Pays-Bas</country><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Nagai, Hirofumi" sort="Nagai, Hirofumi" uniqKey="Nagai H" first="Hirofumi" last="Nagai">Hirofumi Nagai</name><affiliation wicri:level="3"><inist:fA14 i1="14"><s1>Terumo Corporation</s1><s2>Tokyo</s2><s3>JPN</s3><sZ>14 aut.</sZ></inist:fA14><country>Japon</country><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Paunovic, Dragica" sort="Paunovic, Dragica" uniqKey="Paunovic D" first="Dragica" last="Paunovic">Dragica Paunovic</name><affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Terumo Europe</s1><s2>Leuven</s2><s3>BEL</s3><sZ>15 aut.</sZ></inist:fA14><country>Belgique</country><wicri:noRegion>Terumo Europe</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">EuroIntervention</title><title level="j" type="abbreviated">EuroIntervention</title><idno type="ISSN">1774-024X</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">EuroIntervention</title><title level="j" type="abbreviated">EuroIntervention</title><idno type="ISSN">1774-024X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic agent</term><term>Artery stenosis</term><term>Clinical trial</term><term>Comparative study</term><term>Coronary artery</term><term>Coronary heart disease</term><term>Drug eluting stent</term><term>Human</term><term>Paclitaxel</term><term>Patient</term><term>Randomization</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Cardiopathie coronaire</term><term>Sténose artère</term><term>Randomisation</term><term>Etude comparative</term><term>Artère coronaire</term><term>Paclitaxel</term><term>Homme</term><term>Malade</term><term>Essai clinique</term><term>Anticancéreux</term><term>Stent à élution médicamenteuse</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: We studied the Nobori<<sup>TM</sup>> coronary stent coated with a bioabsorbable polymer and the antiproliferative agent Biolimus A9 which may reduce neointimal formation. Methods and results: Patients undergoing percutaneous coronary intervention for de novo lesions in up to two native coronary arteries, in 29 centres across Europe, Asia and Australia were randomly (2:1) assigned to receive the Biolimus A9 eluting stent Nobori<<sup>TM</sup>> (85 patients) or paclitaxel eluting stent Taxus® (35 patients). The two groups were well matched in baseline characteristics. The primary end point of non-inferiority for in-stent late loss of Nobori<<sup>TM</sup>> stent versus Taxus® stent, at 9 months, was reached with the values of 0.15±0.27 mm with Nobori<<sup>TM</sup>> stent and 0.32±0.33 mm with Taxus® stent (p=0.006). Neointimal volume obstruction was 2.2±6.0% and 8.9±9.2% for Nobori<<sup>TM</sup>> and Taxus® stent respectively (p=0.017). The rates of death, myocardial infarction and any target vessel revascularisation at 9 months were 0%, 4.7%, and 7.1% respectively for Nobori<<sup>TM</sup>> stent, and 0%, 8.6% and 14.3% respectively for Taxus® stent. Clinically-driven target lesion revascularisation rate was 0% for Nobori<<sup>TM</sup>> stent and 2.9% for Taxus® stent. Stent thrombosis rates at 9 months were 0% in both groups. Conclusions: In this trial the Nobori<<sup>TM</sup>> Biolimus A9 eluting stent proved to be safe and effective in reducing neointimal proliferation. The long term safety remains to be confirmed during the extended follow-up period of 5 years.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Australie</li><li>Belgique</li><li>Danemark</li><li>Espagne</li><li>France</li><li>Japon</li><li>Pays-Bas</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Bavière</li><li>Communauté de Madrid</li><li>District de Haute-Bavière</li><li>District de Leipzig</li><li>Grand Manchester</li><li>Hollande-Méridionale</li><li>Région de Kantō</li><li>Saxe (Land)</li><li>Île-de-France</li></region><settlement><li>Leipzig</li><li>Madrid</li><li>Manchester</li><li>Munich</li><li>Rotterdam</li><li>Saint-Denis (Seine-Saint-Denis)</li><li>Tokyo</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name></region></country><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W." last="Serruys">Patrick W. Serruys</name></region><name sortKey="Bressers, Marco" sort="Bressers, Marco" uniqKey="Bressers M" first="Marco" last="Bressers">Marco Bressers</name><name sortKey="Suryapranata, Harry" sort="Suryapranata, Harry" uniqKey="Suryapranata H" first="Harry" last="Suryapranata">Harry Suryapranata</name></country><country name="Allemagne"><region name="Bavière"><name sortKey="Silber, Sigmund" sort="Silber, Sigmund" uniqKey="Silber S" first="Sigmund" last="Silber">Sigmund Silber</name></region><name sortKey="Hauptmann, Karl" sort="Hauptmann, Karl" uniqKey="Hauptmann K" first="Karl" last="Hauptmann">Karl Hauptmann</name><name sortKey="Schuler, Gerhard" sort="Schuler, Gerhard" uniqKey="Schuler G" first="Gerhard" last="Schuler">Gerhard Schuler</name></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Garcia, Eulogio" sort="Garcia, Eulogio" uniqKey="Garcia E" first="Eulogio" last="Garcia">Eulogio Garcia</name></region></country><country name="Belgique"><noRegion><name sortKey="Wijns, William" sort="Wijns, William" uniqKey="Wijns W" first="William" last="Wijns">William Wijns</name></noRegion><name sortKey="Paunovic, Dragica" sort="Paunovic, Dragica" uniqKey="Paunovic D" first="Dragica" last="Paunovic">Dragica Paunovic</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Fath Ordoubadi, Farzin" sort="Fath Ordoubadi, Farzin" uniqKey="Fath Ordoubadi F" first="Farzin" last="Fath-Ordoubadi">Farzin Fath-Ordoubadi</name></region></country><country name="Australie"><noRegion><name sortKey="Worthley, Stephen" sort="Worthley, Stephen" uniqKey="Worthley S" first="Stephen" last="Worthley">Stephen Worthley</name></noRegion><name sortKey="Meredith, Ian" sort="Meredith, Ian" uniqKey="Meredith I" first="Ian" last="Meredith">Ian Meredith</name></country><country name="Danemark"><noRegion><name sortKey="Thuesen, Leif" sort="Thuesen, Leif" uniqKey="Thuesen L" first="Leif" last="Thuesen">Leif Thuesen</name></noRegion></country><country name="Japon"><region name="Région de Kantō"><name sortKey="Nagai, Hirofumi" sort="Nagai, Hirofumi" uniqKey="Nagai H" first="Hirofumi" last="Nagai">Hirofumi Nagai</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009386 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009386 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:07-0102184
|texte= Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries : the Nobori 1 trial
}}
| This area was generated with Dilib version V0.6.33. |  |